LETTER
Functionalized 2,5-Disubstituted Benzazepines
1397
(8) For an analogous route to a secondary, rather than tertiary
lactam, see: Berney, D.; Schuh, K. Helv. Chim. Acta 1981,
64, 373.
H, J = 7.2 Hz), 7.35–7.39 (m, 2 H). 1H NMR NOESY
analysis indicated that 5b is the assigned cis diastereomer.
(12) Reduction of Nitrile 5a or 5b to Give Aminomethyl
Benzazepines 3a and 3b. Compound 3a as major
(9) Synthesis of 3-Methyl-7-(methyloxy)-8-
{[(methyloxy)methyl]oxy}-1-phenyl-2,3-dihydro-1H-3-
benzazepine (4): To a –78 °C solution of lactam 9 (2.63 g,
7.72 mmol) in anhyd THF (50 mL) under N2 was added via
syringe 1.5 M DIBALH in toluene (6.69 mmol, 10.04
mmol). The mixture was stirred at –78 °C for 2 h, allowed to
warm to ambient temperature and stirred for 16 h. The
mixture was quenched by slow addition of sat. aq NH4Cl (75
mL). The mixture was extracted with 1:1 hexane–EtOAc
(150 mL). The organic layer was separated and stirred
rapidly for 2 h with sat. aq sodium potassium tartrate. The
organic layer was separated, dried over Na2SO4, filtered and
concentrated to afford a yellow oil. Purification by silica gel
chromatography (2:1 hexanes–EtOAc as eluant) gave 1.29 g
(51%) of product. 1H NMR (400 MHz, CDCl3): d = 2.62 (s,
3 H), 3.43 (s, 3 H), 3.49–3.56 (m, 2 H), 3.85, (s, 3 H), 4.42
(d, 1 H, J = 5.2 Hz), 5.02 (d, 1 H, J = 11.2 Hz), 5.06 (d, 1 H,
J = 6.4 Hz), 5.10 (d, 1 H, J = 6.4 Hz), 5.88 (d, 1 H, J = 11.2
Hz), 6.63 (s, 1 H), 6.73 (s, 1 H), 7.08 (d, 2 H, J = 7.6 Hz),
7.16 (t, 1 H, J = 7.2 Hz), 7.25 (d, 2 H, J = 7.6 Hz).
diastereomer: To a solution of 50 mg of 5a (0.142 mmol) in
THF (2.0 mL) was added 4 mL H2O, followed by 15 mg
(0.395 mmol) LiAlH4. The mixture was stirred for 45 min
and an additional 17 mg (0.45 mmol) of LiAlH4 was added.
The mixture was stirred for 30 min and, after cooling to 0 °C
quenched by addition of 30 mL H2O, 30 mL 15% NaOH and
60 mL H2O. The mixture was filtered through a pad of Celite
and concentrated to afford a quantitative yield of product 3
judged by 1H NMR to be an 11:1 mixture of 3a and 3b. 1H
NMR (400 MHz, CDCl3): d = 2.42 (s, 3 H), 2.60–2.73 (m, 2
H), 2.75–2.84 (m, 2 H), 3.10 (dd, 1 H, J = 14.0, 10.0 Hz),
3.20–3.30 (m, 4 H), 3.38 (s, 3 H), 3.75 (t, 1 H, J = 4.5 Hz),
3.85 (s, 3 H), 4.40 (dd, 1 H, J = 8.0, 3.0 Hz), 4.98 (d, 1 H,
J = 6.4 Hz), 5.01 (d, 1 H, J = 6.4 Hz), 6.48 (s, 1 H), 6.67 (s,
1 H), 7.15 (d, 2 H, J = 7.0 Hz), 7.25 (t, 1 H, J = 7.0 Hz), 7.32
(t, 1 H, J = 7.0 Hz). Compound 3b as major diastereomer:
The same procedure as was employed above was carried out
on 5b (101.4 mg, 0.288 mmol) using 6 mL H2O (0.33 mmol)
and 27 mg (0.71 mmol) LiAlH4 in 4 mL THF to supply a
quantitative yield of 3 judged to be a 1:7 mixture of 3a:3b.
1H NMR (400 MHz, CDCl3): d = 2.60 (s, 3 H), 2.63–2.81 (m,
4 H), 2.99 (dd, 1 H, J = 14.4, 3.2 Hz), 3.21 (d, 1 H, J = 14.1
Hz), 3.32 (s, 3 H), 3.47 (dd, 1 H, J = 14.4, 10.0 Hz), 3.71–
3.74 (m, 2 H), 3.83 (s, 3 H), 4.46 (dd, 1 H, J = 10.0, 2.8 Hz),
4.91 (d, 1 H, J = 6.4 Hz), 4.93 (d, 1 H, J = 6.4 Hz), 6.38 (s,
1 H), 6.62 (s, 1 H), 7.11 (d, 2 H, J = 6.8 Hz), 7.23 (t, 1 H,
J = 6.8 Hz), 7.31 (t, 2 H, J = 7.2 Hz).
(10) Synthesis of trans-3-Methyl-8-(methyloxy)-7-
{[(methyloxy)methyl]oxy}-5-phenyl-2,3,4,5-tetrahydro-
1H-3-benzazepine-2-carbonitrile (5a): To a solution of
enamine 4 (1.29 g, 3.96 mmol) in MeOH (70 mL) was added
KCN (1.29 g, 19.8 mmol) followed by pH 7.2 phosphate
buffer (15 mL). The mixture was stirred at ambient
temperature for 3 d. The solvent was removed and the
mixture was partitioned between H2O (50 mL) and 2:1
hexane–EtOAc (75 mL). The organic layer was separated,
dried over Na2SO4, filtered and concentrated to afford 1.16 g
(83%) of product as a pale yellow solid judged to be a >15:1
mixture of 5a:5b by 1H NMR. Anal. Calcd for C21H24N2O3:
C, 71.56; H, 6.86; N, 7.95. Found: C, 71.29; H, 7.09; N, 7.55.
A sample of diastereomerically pure 5a (0.63 g) was
obtained by recrystallization from Et2O as a white solid, mp
157–158 °C. 1H NMR (400 MHz, CDCl3): d = 2.47 (s, 3 H),
2.71 (dd, 1 H, J = 15.0, 6.1 Hz), 3.02 (t, 2 H, J = 6.7 Hz),
3.48 (m, 1 H), 3.50 (s, 3 H), 3.87 (m, 1 H), 3.88 (s, 3 H), 4.15
(d, 1 H, J = 4.8 Hz), 5.18 (d, 1 H, J = 6.9 Hz), 5.21 (d, 1 H,
J = 6.9 Hz), 6.69 (s, 1 H), 6.98 (s, 1 H), 7.08 (d, 2 H, J = 7.5
Hz), 7.17 (t, 1 H, J = 7.6 Hz), 7.24–7.28 (m, 2 H). 1H NMR
NOESY analysis indicated that 5a is the trans diastereomer
as assigned.
(13) A possible explanation for the difference in the high
diastereoselectivity of the cyanide addition to 4 (Scheme 2)
compared to poor selectivity of the LiAlH4 reduction under
anhydrous conditions may be the fact that both are under
thermodynamic control but involve distinct amine
protonation states. At pH 7.2 there may be a strong
thermodynamic preference for the protonated form of 5a
relative to the protonated form of 5b, while under the
conditions of the reduction there may be little
thermodynamic bias between free base 5a and 5b.
Experiments to further examine this question by attempting
the epimerization of 5a or 5b under more basic conditions in
the presence of a proton source have not been carried out.
(14) N-{[(2R*,5R*)-7-Hydroxy-3-methyl-8-(methyloxy)-5-
phenyl-2,3,4,5-tetrahydro-1H-3-benzazepin-2-
(11) cis-3-Methyl-8-(methyloxy)-7-
yl]methyl}-1-methyl-1H-indole-2-carboxamide
{[(methyloxy)methyl]oxy}-5-phenyl-2,3,4,5-tetrahydro-
1H-3-benzazepine-2-carbonitrile (5b): The foregoing 15:1
mixture of trans/cis benzazepines 5a and 5b (1.40 g, 3.97
mmol) was dissolved in anhyd THF (60 mL) and the solution
was cooled under N2 to –78 °C. A solution of KHMDS in
toluene (11.9 mL of 0.5 M solution, 5.96 mmol) was added
and the mixture was stirred for 20 min. A solution of 2,6-
tert-butylhydroxytoluene (1.54 g, 7.0 mmol) in THF (10
mL) was added slowly via syringe. The mixture was stirred
for 1 h at –78 °C, allowed to warm to 0 °C, and partitioned
between sat. aq NaHCO3 and 1:1 hexane–EtOAc. The
organic layer was separated and dried over Na2SO4, filtered
and concentrated. Purification by silica gel chromatography
(2:1 hexane–EtOAc) afforded in order of mobility 5a (0.76
g, 2.15 mmol) and 5b (mp 137–138 °C) (0.44 g, 1.25 mmol).
Compound 5b: 1H NMR (400 MHz, CDCl3): d = 2.49 (s, 3
H), 2.92 (dd, 1 H, J = 12.4, 9.6 Hz), 2.99–3.08 (m, 2 H), 3.28
(s, 3 H), 3.48 (d, 1 H, J = 14.8 Hz), 3.84 (s, 3 H), 4.06 (d, 1
H, J = 4.8 Hz), 4.18 (d, 1 H, J = 9.6 Hz), 4.89 (s, 2 H), 6.27
(s, 1 H), 6.73 (s, 1 H), 7.17 (s, 1 H), 7.19 (s, 1 H), 7.29 (t, 1
Hydrochloride (11): To a solution of 7:1 cis/trans
benzazepines 3b:3a obtained from the foregoing procedure
(27.3 mg, 0.077 mmol) and N,N-diisopropylethylamine (27
mL, 0.154 mmol) was added 1-(3-dimethylaminopropyl)-3-
ethylcarbodiimide hydrochloride (21.5 mg, 0.112 mmol),
and N-methyl indole-2-carboxylate (21 mg, 0.12 mmol)
followed by 1-hydroxybenzotriazole monohydrate (3 mg,
0.02 mmol). The solution was stirred at ambient temperature
for 15 h. The mixture was partitioned between H2O and
EtOAc. The organic layer was separated, washed with sat. aq
NaCl, filtered and concentrated to afford the crude product,
which was purified by silica gel chromatography to give
26.0 mg (66% yield) of the pure MOM protected ether amide
product as a 7:1 mixture of diastereomers by 1H NMR. 1H
NMR (major, cis diastereomer) resonances include: d = 2.67
(s, 3 H), 2.78 (dd, 1 H, J = 15.0, 7.2 Hz), 2.97 (br s, 1 H),
3.03 (d, 1 H, J = 14.4 Hz), 3.19 (dt, 1 H, J = 7.7, 3.6 Hz),
3.33 (s, 3 H), 3.53–3.61 (m, 2 H), 3.84 (s, 3 H), 4.04 (s, 2 H),
4.50 (d, 1 H, J = 8.4 Hz), 4.94 (s, 2 H), 6.41 (s, 1 H), 6.66 (s,
1 H), 6.74 (s, 1 H), 7.11–7.15 (m, 3 H), 7.24–7.38 (m, 5 H),
Synlett 2004, No. 8, 1394–1398 © Thieme Stuttgart · New York